Humira & the
Biosimilar Boom
As prescription drug costs continue to rise, payers are looking for ways to mitigate costs. Will biosimilars be an answer? And what impact will a wave of Humira® biosimilars have on employers, health plans and their members?
This exclusive RxSS webinar answers these questions and provides insight you won’t find anywhere else.
WHAT's in the Webinar?
Discover potential savings and poll results from benefit leaders on how they are adjusting their biosimilar strategy—and more!
MARKET INSIGHT
Get a snapshot of the biosimilar market, including potential future state.
REBATE PRO TIPS
Learn about the impact rebates could have on your biosimilar strategy and copay program design.
NEXT STEPS
Explore questions and scenarios to discuss with your PBM or consultant.
